Kahraman Günal, Krepler Katharina, Franz Carmen, Ries Eva, Maar Noemi, Wedrich Andreas, Rieger Armin, Dejaco-Ruhswurm Irene
Department of Ophthalmology, Medical University of Vienna, Austria.
Ocul Immunol Inflamm. 2005 Apr-Jun;13(2-3):213-8. doi: 10.1080/09273940490912443.
The widespread use of highly active antiretroviral therapy (HAART) has changed the clinical picture of HIV-associated eye disease. We evaluated the incidence of ocular manifestations of HIV infection since the introduction of HAART.
Between January 1996 and December 2002, we examined 539 HIV-infected patients in our hospital. Follow-up of the patients was performed in case of ophthalmologic symptoms, regardless of current immunologic status, or for screening.
A total of 217 patients (40.3%) had HIV-associated eye disease. Of these patients, 42.0% had no eye symptoms. Fifty-eight (10.8%) of the 539 patients had cytomegalovirus (CMV) retinitis, most of whom had CMV retinitis before receiving HAART. Four patients developed immune-recovery uveitis. A total of 145 patients (26.9%) had HIV-related microangiopathy and 96 (17.8%) had dry-eye syndrome.
The introduction of HAART had a major impact on the medical history of patients with HIV-related eye disease with improved survival time and decreased morbidity.
高效抗逆转录病毒疗法(HAART)的广泛应用改变了HIV相关眼病的临床状况。我们评估了自引入HAART以来HIV感染眼部表现的发生率。
1996年1月至2002年12月期间,我们对我院539例HIV感染患者进行了检查。无论患者当前的免疫状态如何,出现眼科症状时或为进行筛查时均对其进行随访。
共有217例患者(40.3%)患有HIV相关眼病。在这些患者中,42.0%没有眼部症状。539例患者中有58例(10.8%)患有巨细胞病毒(CMV)视网膜炎,其中大多数患者在接受HAART之前就已患有CMV视网膜炎。4例患者发生了免疫重建葡萄膜炎。共有145例患者(26.9%)患有HIV相关微血管病变,96例(17.8%)患有干眼症。
HAART的引入对HIV相关眼病患者的病史产生了重大影响,患者生存时间延长,发病率降低。